Xtx Topco LTD Lyell Immunopharma, Inc. Transaction History

Xtx Topco LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$1.3 - $3.01 $52,708 - $122,040	-40,545 Reduced 36.62%	70,174 $101,000
Q1 2024 May 13, 2024	SELL	$1.71 - $3.07 $76,392 - $137,149	-44,674 Reduced 28.75%	110,719 $246,000
Q4 2023 Feb 13, 2024	BUY	$1.39 - $2.35 $56,535 - $95,581	40,673 Added 35.45%	155,393 $301,000
Q3 2023 Nov 13, 2023	BUY	$1.45 - $3.35 $166,344 - $384,312	114,720 New	114,720 $168,000
Q1 2023 May 12, 2023	BUY	$1.97 - $3.58 $533,846 - $970,137	270,988 Added 1734.21%	286,614 $676,000
Q4 2022 Feb 14, 2023	BUY	$2.78 - $8.09 $43,440 - $126,414	15,626 New	15,626 $54,000

122

142M

18.1K

200

Ticker LYEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 247,824,992
Market Cap $273M
Description
Lyell Immunopharma, Inc., a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. The company develops therapies using technology platforms, such as Gen-R, an ex vivo genetic reprogramming technology to overcome T cell exhaustion; and Epi-R, an ex vivo epigenetic reprogramming technology to generate...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.